Scarica l'app Stockscreener
1.83
2.23%
0.04
Akebia Therapeutics Inc Azioni (AKBA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
41.98%
32.61
|
56.20 | 42.05 | 56.38 | 40.13 |
| Cost Of Revenue |
37.82%
11.61
|
18.66 | 18.01 | 17.28 | 19.48 |
| Gross Profit |
44.04%
21.00
|
37.53 | 24.04 | 39.09 | 20.64 |
Operating Expenses
|
0.61%
35.94
|
36.16 | 37.07 | 48.09 | 45.58 |
| Benefits Costs and Expenses |
79.48%
50.59
|
246.55 | - | - | - |
| Costs And Expenses |
16.36%
50.59
|
60.49 | 55.08 | 65.37 | 65.06 |
| Operating Income/Loss |
1,187%
-14.94
|
1.374 | -13.04 | -8.996 | -25.60 |
| Income/Loss From Continuing Operations Before Tax |
90.55%
-17.98
|
-190.35 | 42.05 | -11.17 | -26.88 |
| Income/Loss From Continuing Operations After Tax |
3,029%
-17.98
|
0.614 | -14.49 | -11.17 | -26.88 |
|
Net Income/Loss
|
3,029%
-17.98
|
0.614 | -14.49 | -11.17 | -26.88 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
24,847%
204.96
|
0.8216 | 188.31 | 186.82 | 184.77 |
| Diluted Average Shares |
24,847%
204.96
|
0.8216 | 188.31 | 186.82 | 184.77 |
| Basic Earnings Per Share |
-0.09
|
- | -0.08 | -0.06 | -0.15 |
| Diluted Earnings Per Share |
-0.09
|
- | -0.08 | -0.06 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.61%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):